Endorsements

The UB Chair recommends requesting its scientific endorsement for any scientific training and/or lecturing event related to the content of the speciality of precision oncology that is in line with the aims of the scientific society. Granting of this endorsement is a way of validating this activity by the UB Chair of Innovation in Precision Oncology.

Endorsement/organisation of Call for 3 Pre-doctoral Fellowships (€90,000): With 5 winning students (3 women and 2 men), these fellowships promote gender equality and provide financial support to young researchers for their doctoral theses.
request endorsement


EPARADELL@clinic.cat

Activities we have already endorsed...

Year Date Type Activity title
2024 04-12-24 Aval C17 Update conference on urological tumors read more
2024 C10 y 11/12/2024 Aval I Comprehensive training for professional development and well-being in oncology for residents and young adjuncts. Module 1. Time management read more
2024 C10 y 11/12/2024 Aval I Comprehensive training for professional development and well-being in oncology for residents and young adjuncts. Module 1. Time management
I Genetic counseling conference for patients with hereditary cancer prediposition syndromes
read more
2024 Es 08-11-24 Aval VIII Conference C17 on lung cancer read more
2024 12-12-24 Aval Challenges and strategies in the management of frail and elderly patients in advanced NSCLC in the first line read more
2024 09-11-24 Aval I Genetic counseling conference for patients with hereditary cancer prediposition syndromes read more
2024 24, 31/10 y 7/11/24 Aval VII Conference C17. Update course in gynaecolgical oncology read more
2024 18-10-24 Aval World Breast Cancer Day 2024 read more
2024 01-09-24 Aval Video capsules for networks: role of oncologist doctor
2024 07-06-24 Aval C17 Multidisciplinary consensus for the best locoregional approach to breast cancer 2024
2024 13-05-24 Aval Sinergy workshop on translational & clinical oncology applied to environmental & occupational cancer: focus on radon read more
2023 15/11/23 Aval Aseica placement read more
2023 10/11/23 Aval VII Day C17: Lung cancer read more
2023 8-9/11/23 Aval Workshop C17 Refresher in Urological Tumours read more
2023 19/10/23 Aval World Breast Cancer Day read more
2023 9/06/23 Aval VII Day C17: Breast cancer read more
2023 En curso Aval EPIMETEO read more
2022 30/11/22 Aval VI Workshop C17: Update on Urological Tumours read more
2022 19/10/22 Aval World Breast Cancer Day - WBCD read more
2022 17/06/22 Aval VI Day C17: Breast cancer read more
2022 10/05/22 Aval 1st Edition Expertalks on Breast Cancer read more
2022 24/01/22 Aval Course "Reimagine your trial" read more
2021 19/11/21 Aval Up-to-date summit Solti read more
2021 19/10/21 Aval World Breast Cancer Day read more
2021 17/07/21 Aval VI Day C17: Breast cancer read more
2021 20/05/21 Aval SOLTI. Up-To-Date Summit 2021 read more
2021 01/01/21 Aval PAIC eHAP Programme read more

Knowledge in precision oncology

Expertalks is a series of exclusive events where we talk about new topics in precision oncology from experience and personal opinion.

Previously at EXPERTALKS...

Clinical implications of the intrinsic subtypes of breast cancer: HR+/HER2- disease

Welcome, presentation of the expert and lecture

DRA. MARIA VIDAL Y DR. ALEIX PRAT
Debate

DR. ALEIX PRAT, DRA. MARIA VIDAL, DR. CÉSAR A. RODRÍGUEZ, DR. JOAQUÍN GAVILÁ Y DRA. ELENA GALVE

EXPERT

Dr. Aleix Prat

Hospital Clínic Barcelona-IDIBAPS

COORDINATOR

Dra. Maria Vidal

Hospital Clínic de Barcelona

MODERATOR

Dr. César A. Rodríguez

Hospital Universitario de Salamanca

SPEAKER

Dr. Joaquín Gavilá

Instituto Valenciano de Oncología (IVO)

SPEAKER

Dra. Elena Galve

Hospital Universitario Basurto

Discussions on controversies in the treatment of breast cancer

H2H DEBATES is a meeting space for oncology specialists where the most up-to-date data on breast cancer treatments are presented and discussed.

Previously in H2H DEBATES...

CDK4/6 inhibitors in breast cancer: choosing the best.

Presentation

DR. ALEIX PRAT
Abemaciclib

DRA. MERITXELL BELLET
Palbociclib

DRA. MIREIA MARGELÍ
Ribociclib

DRA. MARIA VIDAL
Debate and conclusions

DR. ALEIX PRAT, DRA. MIREIA MARGELÍ, DRA. MARIA VIDAL Y DRA. MERITXELL BELLET

Would you like to access the Annual Report of Activities of the UB Chair?